Alnylam Pharmaceuticals 10K 2007 Annual report | ALNY Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: acquiree, Add, adjudged, altogether, Amarin, amassed, AMR, analogy, angiogenic, ARB, Archemix, Arrow, ascertain, AstraZeneca, Asuragen, atherogenic, authoritative, autosomal, Avicena, balloon, Basel, Bayer, beneficiary, biodefense, BiologyandNature, book, breast, CA, Canadian, carbohydrate, cardiovascular, carryforward, Center, CFTT, cGMP, chemoembolism, chemotherapy, cholinesterase, chromosome, classification, clearer, colorectal, complicated, contra, creatine, cure, databank, decade, deferral, deliverable, deposit, derecognition, Dicerna, die, Dimebontm, disagree, disorderly, DoD, dominant, downgrade, DTRA, dual, durable, eicosapentaenoic, EITFNo, embrace, England, enjoined, EPA, erosion, exciting, expectEITF, explicitly, FDAAA, fish, freedom, GAAP, GEMINI, Genzyme, glutamate, Harvard, HCC, hearing, hemorrgagic, hepatic, Hepatocellular, hierarchy, inconsequential, inexorable, inflammatory, inNature, instruct, intolerant, intramuscular, IV, Journal, JP, kinesin, KSP, largest, LCA, leadership, likelihood, Linsley, LLP, master, Medivation, metastasized, metastatic, microRNA, military, mipomersen, Miragen, Miraxion, miRNA, mission, MIT, mitigation, mitochondrial, monetary, monetize, mortgage, motavizumab, MPTP, multiplying, mutant, nanoparticle, nebulizer, neoplasm, neurobehavioral, neuroprotective, Nexavar, ninety, NMDA, NOL, noncontrolling, nonexclusive, nonfinancial, nonrecurring, Numax, ofEITF, oil, Onyx, open, Opko, opt, pace, paragraph, peptide, perfunctory, permeability, Peter, pharmacokinetic, pioneering, political, poor, pore, pose, presentedin, primate, Professor, proliferation, purported, radiation, randomized, ratio, rational, reexamination, refined, rentable, resectable, resection, resolution, reward, Rosetta, sampling, satisfactory, Science, Scolnick, secondary, sector, settlement, shift, skin, Sorafenib, spindle, standalone, statistically, steering, stomach, Sublease, subleased, subpopulation, successor, sunset, supplier, surgical, symptomatic, Tekmira, theNew, thepreventionof, toEITF, traditional, Transformational, transplantation, unapproved, undelivered, UTSW, venture, versa, vivodata, wild, Zealand

Removed: abnormally, accretion, acuity, adapt, alleviate, allocate, Alzheimer, AMD, amounting, annum, apparent, assume, Atamet, azithromycin, bank, bear, biodistribution, boosting, cancelled, CFTR, Chiron, clinically, cold, compare, composition, concept, conductance, constant, consultant, consulting, converted, convertible, cord, culture, cumbersome, damage, deal, deducting, defend, degeneration, degrade, derive, description, discretion, disorder, dopamine, dose, earn, employ, entacapone, exceed, facilitate, fall, faster, fluid, gained, Genasense, geographical, Harbor, hedge, helicase, illegal, importance, Improvement, incubation, indemnified, indemnity, inhalation, introducing, investigate, landlord, macular, match, methylprednisolone, mimicking, modification, narrow, nogo, operation, output, outweigh, owed, packed, PD, penetrate, Perman, productive, prolong, promulgate, proper, protectionist, Pulmozyme, readily, redeemable, reducing, regeneration, regulator, reimbursable, released, removed, Rental, repayment, Requip, SCI, Secretary, shareholder, Sinemet, solution, source, spinal, Spring, Stabilization, stabilized, steroid, supported, tenant, TOBI, tobramycin, trailing, transmembrane, travel, twenty, undergoing, vulnerable, warned, Washington

Alnylam Pharmaceuticals (ALNY) 10-K2007 FY Annual report

Content analysis